# Methylphenidate in Treating Patients With Fatigue Caused by Cancer

> **NCT00376675** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 148 (actual)

## Conditions studied

- Fatigue
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** methylphenidate hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00376675
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2016-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376675, "Methylphenidate in Treating Patients With Fatigue Caused by Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00376675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*